Shares of Frontier IP Group Plc (LON:FIPP – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 14.82 and traded as high as GBX 17. Frontier IP Group shares last traded at GBX 17, with a volume of 108,180 shares.
Frontier IP Group Price Performance
The company has a debt-to-equity ratio of 31.75, a quick ratio of 23.03 and a current ratio of 4.61. The stock has a market cap of £12.12 million, a price-to-earnings ratio of -1.36 and a beta of 0.51. The business’s fifty day simple moving average is GBX 14.88 and its 200 day simple moving average is GBX 15.50.
Frontier IP Group (LON:FIPP – Get Free Report) last issued its quarterly earnings data on Monday, March 30th. The company reported GBX (4.54) EPS for the quarter. Frontier IP Group had a negative return on equity of 19.23% and a negative net margin of 2,477.36%.The firm had revenue of GBX 13 million during the quarter.
Frontier IP Group Company Profile
Frontier IP Group builds value by uniting science, industry and finance to commercialise university intellectual property.
Our strategy is based on proving the commercial worth of IP developed by our portfolio companies before raising significant sums of money to support their further growth. We earn equity stakes in return for providing a range of hands-on commercialisation services.
The spin outs we work with include those at the cutting edge of developing new vaccines and antibiotics, agricultural robotics, sustainable materials and improving the energy efficiency of solar cells and power converters.
Our portfolio companies’ IP is based on research from universities in the UK and Portugal, including Cambridge, Plymouth, Heriot-Watt, the University of Central Lancashire, NOVA University, Lisbon FCT NOVA, and INESC TEC.
Featured Stories
- Five stocks we like better than Frontier IP Group
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Frontier IP Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Frontier IP Group and related companies with MarketBeat.com's FREE daily email newsletter.
